Elite in Hepato-Pancreato-Biliary Surgery

Luca A. Aldrighetti

Milan, IT 
Elite in Hepato-Pancreato-Biliary Surgery
Milan, IT 
OverviewLocationsClinical Research

Overview

Luca Aldrighetti practices in Milan, Italy. Mr. Aldrighetti is rated as an Elite expert by MediFind in Hepato-Pancreato-Biliary Surgery. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Liver Failure, Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

His clinical research consists of co-authoring 562 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 134 articles in the study of Hepato-Pancreato-Biliary Surgery.

Gender
Male

Locations

Milan, Italy
Other Locations
San Raffaele, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The ORANGE SEGMENTS - Trial: an International Multicentre Randomized Controlled Trial of Open Versus Laparoscopic Parenchymal Preserving Postero-superior Liver Segment Resection
The ORANGE SEGMENTS - Trial: an International Multicentre Randomized Controlled Trial of Open Versus Laparoscopic Parenchymal Preserving Postero-superior Liver Segment Resection
Enrollment Status: Active_not_recruiting
Publish Date: May 19, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
The ORANGE II PLUS - Trial: an International Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Hemihepatectomies.
The ORANGE II PLUS - Trial: an International Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Hemihepatectomies.
Enrollment Status: Completed
Publish Date: May 18, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy
Enrollment Status: Unknown
Publish Date: February 03, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

562 Total Publications

ASO Visual Abstract: Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma.
ASO Visual Abstract: Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma.
Journal: Annals of surgical oncology
Published: August 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Aldrighetti's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile